Selected research
Market Outlook & Growth Opportunities
Global Adeno-Associated Virus (AAV) Packaging Service Market Outlook and Growth Opportunities 2026
Market perspective
The global Adeno-Associated Virus (AAV) Packaging Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Adeno-Associated Virus (AAV) Packaging Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Adeno-Associated Virus (AAV) Packaging Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Adeno-Associated Virus (AAV) Packaging Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Adeno-Associated Virus (AAV) Packaging Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Adeno-Associated Virus (AAV) Packaging Service market include GenScript, Abace Biology, Genecfps, GENEWIZ, Obio Technology, Charles River Laboratories, Takara Bio, abm and Cell Biolabs, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Adeno-Associated Virus (AAV) Packaging Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Adeno-Associated Virus (AAV) Packaging Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Adeno-Associated Virus (AAV) Packaging Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Adeno-Associated Virus (AAV) Packaging Service market.
Adeno-Associated Virus (AAV) Packaging Service Segment by Company
GenScript
Abace Biology
Genecfps
GENEWIZ
Obio Technology
Charles River Laboratories
Takara Bio
abm
Cell Biolabs
Cyagen
Vector Biolabs
Lonza
Oxford BioMedica
Catalent
Wuxi Shengji Pharmaceuticals
Boten Biotech
Cytiva
Packgene
VectorBuilder
Ubigene
Adeno-Associated Virus (AAV) Packaging Service Segment by Type
Small Scale
Medium Scale
Large Scale
Adeno-Associated Virus (AAV) Packaging Service Segment by Application
Gene Therapy
Scientific Research
Adeno-Associated Virus (AAV) Packaging Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Adeno-Associated Virus (AAV) Packaging Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Adeno-Associated Virus (AAV) Packaging Service key companies, revenue, market share, and recent developments.
3. To split the Adeno-Associated Virus (AAV) Packaging Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Adeno-Associated Virus (AAV) Packaging Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Adeno-Associated Virus (AAV) Packaging Service significant trends, drivers, influence factors in global and regions.
6. To analyze Adeno-Associated Virus (AAV) Packaging Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Adeno-Associated Virus (AAV) Packaging Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Adeno-Associated Virus (AAV) Packaging Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Adeno-Associated Virus (AAV) Packaging Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Adeno-Associated Virus (AAV) Packaging Service industry.
Chapter 3: Detailed analysis of Adeno-Associated Virus (AAV) Packaging Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Adeno-Associated Virus (AAV) Packaging Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Adeno-Associated Virus (AAV) Packaging Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Small Scale
- Medium Scale
- Large Scale
Applications
- Gene Therapy
- Scientific Research
Companies covered
- GenScript
- Abace Biology
- Genecfps
- GENEWIZ
- Obio Technology
- Charles River Laboratories
- Takara Bio
- abm
- Cell Biolabs
- Cyagen
- Vector Biolabs
- Lonza
- Oxford BioMedica
- Catalent
- Wuxi Shengji Pharmaceuticals
- Boten Biotech
- Cytiva
- Packgene
- VectorBuilder
- Ubigene
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Adeno-Associated Virus (AAV) Packaging Service Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Adeno-Associated Virus (AAV) Packaging Service Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Adeno-Associated Virus (AAV) Packaging Service Market Dynamics
- 2.1 Adeno-Associated Virus (AAV) Packaging Service Industry Trends
- 2.2 Adeno-Associated Virus (AAV) Packaging Service Industry Drivers
- 2.3 Adeno-Associated Virus (AAV) Packaging Service Industry Opportunities and Challenges
- 2.4 Adeno-Associated Virus (AAV) Packaging Service Industry Restraints
3 Adeno-Associated Virus (AAV) Packaging Service Market by Company
- 3.1 Global Adeno-Associated Virus (AAV) Packaging Service Company Revenue Ranking in 2025
- 3.2 Global Adeno-Associated Virus (AAV) Packaging Service Revenue by Company (2021-2026)
- 3.3 Global Adeno-Associated Virus (AAV) Packaging Service Company Ranking (2024-2026)
- 3.4 Global Adeno-Associated Virus (AAV) Packaging Service Company Manufacturing Base and Headquarters
- 3.5 Global Adeno-Associated Virus (AAV) Packaging Service Company Product Type and Application
- 3.6 Global Adeno-Associated Virus (AAV) Packaging Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Adeno-Associated Virus (AAV) Packaging Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Adeno-Associated Virus (AAV) Packaging Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Adeno-Associated Virus (AAV) Packaging Service Market by Type
- 4.1 Adeno-Associated Virus (AAV) Packaging Service Type Introduction
- 4.1.1 Small Scale
- 4.1.2 Medium Scale
- 4.1.3 Large Scale
- 4.2 Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Type
- 4.2.1 Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Type (2021-2032)
- 4.2.3 Global Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Type (2021-2032)
5 Adeno-Associated Virus (AAV) Packaging Service Market by Application
- 5.1 Adeno-Associated Virus (AAV) Packaging Service Application Introduction
- 5.1.1 Gene Therapy
- 5.1.2 Scientific Research
- 5.2 Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Application
- 5.2.1 Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Application (2021-2032)
- 5.2.3 Global Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Application (2021-2032)
6 Adeno-Associated Virus (AAV) Packaging Service Regional Value Analysis
- 6.1 Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Region (2021-2032)
- 6.2.1 Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Region: 2021-2026
- 6.2.2 Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Adeno-Associated Virus (AAV) Packaging Service Sales Value (2021-2032)
- 6.3.2 North America Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Adeno-Associated Virus (AAV) Packaging Service Sales Value (2021-2032)
- 6.4.2 Europe Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Adeno-Associated Virus (AAV) Packaging Service Sales Value (2021-2032)
- 6.6.2 South America Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Adeno-Associated Virus (AAV) Packaging Service Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Country, 2025 VS 2032
7 Adeno-Associated Virus (AAV) Packaging Service Country-level Value Analysis
- 7.1 Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Country (2021-2032)
- 7.2.1 Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Country (2021-2026)
- 7.2.2 Global Adeno-Associated Virus (AAV) Packaging Service Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Adeno-Associated Virus (AAV) Packaging Service Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Adeno-Associated Virus (AAV) Packaging Service Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Adeno-Associated Virus (AAV) Packaging Service Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Adeno-Associated Virus (AAV) Packaging Service Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Adeno-Associated Virus (AAV) Packaging Service Sales Value Growth Rate (2021-2032)
- 7.7.2 France Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Adeno-Associated Virus (AAV) Packaging Service Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Adeno-Associated Virus (AAV) Packaging Service Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Adeno-Associated Virus (AAV) Packaging Service Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Adeno-Associated Virus (AAV) Packaging Service Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Adeno-Associated Virus (AAV) Packaging Service Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Adeno-Associated Virus (AAV) Packaging Service Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Adeno-Associated Virus (AAV) Packaging Service Sales Value Growth Rate (2021-2032)
- 7.14.2 China Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Adeno-Associated Virus (AAV) Packaging Service Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Adeno-Associated Virus (AAV) Packaging Service Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Adeno-Associated Virus (AAV) Packaging Service Sales Value Growth Rate (2021-2032)
- 7.17.2 India Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Adeno-Associated Virus (AAV) Packaging Service Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Adeno-Associated Virus (AAV) Packaging Service Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Adeno-Associated Virus (AAV) Packaging Service Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Adeno-Associated Virus (AAV) Packaging Service Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Adeno-Associated Virus (AAV) Packaging Service Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Adeno-Associated Virus (AAV) Packaging Service Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Adeno-Associated Virus (AAV) Packaging Service Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Adeno-Associated Virus (AAV) Packaging Service Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Adeno-Associated Virus (AAV) Packaging Service Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Adeno-Associated Virus (AAV) Packaging Service Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Adeno-Associated Virus (AAV) Packaging Service Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Adeno-Associated Virus (AAV) Packaging Service Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Adeno-Associated Virus (AAV) Packaging Service Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Adeno-Associated Virus (AAV) Packaging Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 GenScript
- 8.1.1 GenScript Company Information
- 8.1.2 GenScript Business Overview
- 8.1.3 GenScript Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)
- 8.1.4 GenScript Adeno-Associated Virus (AAV) Packaging Service Product Portfolio
- 8.1.5 GenScript Recent Developments
- 8.2 Abace Biology
- 8.2.1 Abace Biology Company Information
- 8.2.2 Abace Biology Business Overview
- 8.2.3 Abace Biology Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)
- 8.2.4 Abace Biology Adeno-Associated Virus (AAV) Packaging Service Product Portfolio
- 8.2.5 Abace Biology Recent Developments
- 8.3 Genecfps
- 8.3.1 Genecfps Company Information
- 8.3.2 Genecfps Business Overview
- 8.3.3 Genecfps Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)
- 8.3.4 Genecfps Adeno-Associated Virus (AAV) Packaging Service Product Portfolio
- 8.3.5 Genecfps Recent Developments
- 8.4 GENEWIZ
- 8.4.1 GENEWIZ Company Information
- 8.4.2 GENEWIZ Business Overview
- 8.4.3 GENEWIZ Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)
- 8.4.4 GENEWIZ Adeno-Associated Virus (AAV) Packaging Service Product Portfolio
- 8.4.5 GENEWIZ Recent Developments
- 8.5 Obio Technology
- 8.5.1 Obio Technology Company Information
- 8.5.2 Obio Technology Business Overview
- 8.5.3 Obio Technology Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)
- 8.5.4 Obio Technology Adeno-Associated Virus (AAV) Packaging Service Product Portfolio
- 8.5.5 Obio Technology Recent Developments
- 8.6 Charles River Laboratories
- 8.6.1 Charles River Laboratories Company Information
- 8.6.2 Charles River Laboratories Business Overview
- 8.6.3 Charles River Laboratories Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)
- 8.6.4 Charles River Laboratories Adeno-Associated Virus (AAV) Packaging Service Product Portfolio
- 8.6.5 Charles River Laboratories Recent Developments
- 8.7 Takara Bio
- 8.7.1 Takara Bio Company Information
- 8.7.2 Takara Bio Business Overview
- 8.7.3 Takara Bio Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)
- 8.7.4 Takara Bio Adeno-Associated Virus (AAV) Packaging Service Product Portfolio
- 8.7.5 Takara Bio Recent Developments
- 8.8 abm
- 8.8.1 abm Company Information
- 8.8.2 abm Business Overview
- 8.8.3 abm Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)
- 8.8.4 abm Adeno-Associated Virus (AAV) Packaging Service Product Portfolio
- 8.8.5 abm Recent Developments
- 8.9 Cell Biolabs
- 8.9.1 Cell Biolabs Company Information
- 8.9.2 Cell Biolabs Business Overview
- 8.9.3 Cell Biolabs Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)
- 8.9.4 Cell Biolabs Adeno-Associated Virus (AAV) Packaging Service Product Portfolio
- 8.9.5 Cell Biolabs Recent Developments
- 8.10 Cyagen
- 8.10.1 Cyagen Company Information
- 8.10.2 Cyagen Business Overview
- 8.10.3 Cyagen Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)
- 8.10.4 Cyagen Adeno-Associated Virus (AAV) Packaging Service Product Portfolio
- 8.10.5 Cyagen Recent Developments
- 8.11 Vector Biolabs
- 8.11.1 Vector Biolabs Company Information
- 8.11.2 Vector Biolabs Business Overview
- 8.11.3 Vector Biolabs Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)
- 8.11.4 Vector Biolabs Adeno-Associated Virus (AAV) Packaging Service Product Portfolio
- 8.11.5 Vector Biolabs Recent Developments
- 8.12 Lonza
- 8.12.1 Lonza Company Information
- 8.12.2 Lonza Business Overview
- 8.12.3 Lonza Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)
- 8.12.4 Lonza Adeno-Associated Virus (AAV) Packaging Service Product Portfolio
- 8.12.5 Lonza Recent Developments
- 8.13 Oxford BioMedica
- 8.13.1 Oxford BioMedica Company Information
- 8.13.2 Oxford BioMedica Business Overview
- 8.13.3 Oxford BioMedica Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)
- 8.13.4 Oxford BioMedica Adeno-Associated Virus (AAV) Packaging Service Product Portfolio
- 8.13.5 Oxford BioMedica Recent Developments
- 8.14 Catalent
- 8.14.1 Catalent Company Information
- 8.14.2 Catalent Business Overview
- 8.14.3 Catalent Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)
- 8.14.4 Catalent Adeno-Associated Virus (AAV) Packaging Service Product Portfolio
- 8.14.5 Catalent Recent Developments
- 8.15 Wuxi Shengji Pharmaceuticals
- 8.15.1 Wuxi Shengji Pharmaceuticals Company Information
- 8.15.2 Wuxi Shengji Pharmaceuticals Business Overview
- 8.15.3 Wuxi Shengji Pharmaceuticals Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)
- 8.15.4 Wuxi Shengji Pharmaceuticals Adeno-Associated Virus (AAV) Packaging Service Product Portfolio
- 8.15.5 Wuxi Shengji Pharmaceuticals Recent Developments
- 8.16 Boten Biotech
- 8.16.1 Boten Biotech Company Information
- 8.16.2 Boten Biotech Business Overview
- 8.16.3 Boten Biotech Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)
- 8.16.4 Boten Biotech Adeno-Associated Virus (AAV) Packaging Service Product Portfolio
- 8.16.5 Boten Biotech Recent Developments
- 8.17 Cytiva
- 8.17.1 Cytiva Company Information
- 8.17.2 Cytiva Business Overview
- 8.17.3 Cytiva Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)
- 8.17.4 Cytiva Adeno-Associated Virus (AAV) Packaging Service Product Portfolio
- 8.17.5 Cytiva Recent Developments
- 8.18 Packgene
- 8.18.1 Packgene Company Information
- 8.18.2 Packgene Business Overview
- 8.18.3 Packgene Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)
- 8.18.4 Packgene Adeno-Associated Virus (AAV) Packaging Service Product Portfolio
- 8.18.5 Packgene Recent Developments
- 8.19 VectorBuilder
- 8.19.1 VectorBuilder Company Information
- 8.19.2 VectorBuilder Business Overview
- 8.19.3 VectorBuilder Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)
- 8.19.4 VectorBuilder Adeno-Associated Virus (AAV) Packaging Service Product Portfolio
- 8.19.5 VectorBuilder Recent Developments
- 8.20 Ubigene
- 8.20.1 Ubigene Company Information
- 8.20.2 Ubigene Business Overview
- 8.20.3 Ubigene Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2021-2026)
- 8.20.4 Ubigene Adeno-Associated Virus (AAV) Packaging Service Product Portfolio
- 8.20.5 Ubigene Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst